• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Tumori. Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di M

tetano

Editor, Senior Moderator
Tumori. 2020 May 4:300891620923790. doi: 10.1177/0300891620923790. [Epub ahead of print]
Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano.


Valenza F[SUP]1,[/SUP][SUP]2[/SUP], Papagni G[SUP]1[/SUP], Marchian? A[SUP]3[/SUP], Daidone MG[SUP]4[/SUP], DeBraud F[SUP]2,[/SUP][SUP]5[/SUP], Colombo MP[SUP]6[/SUP], Frignani A[SUP]7[/SUP], Galmozzi G[SUP]8[/SUP], Ladisa V[SUP]9[/SUP], Pruneri G[SUP]2,[/SUP][SUP]10[/SUP], Salvioni R[SUP]11[/SUP], Spada P[SUP]12[/SUP], Torresani M[SUP]13[/SUP], Rinaldi O[SUP]14[/SUP], Manfredi S[SUP]15[/SUP], Votta M[SUP]16[/SUP], Apolone G[SUP]17[/SUP].

Author information




Abstract

BACKGROUND:

The rapid spread of coronavirus disease (COVID-19) is affecting many countries. While healthcare systems need to cope with the need to treat a large number of people with different degrees of respiratory failure, actions to preserve aliquots of the healthcare system to guarantee treatment to patients are mandatory.
METHODS:

In order to protect the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano from the spread of COVID-19, a number of to-hospital and within-hospital filters were applied. Among others, a triage process to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in patients with cancer was developed consisting of high-resolution low-dose computed tomography (CT) scan followed by reverse transcription polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in nose-throat swabs whenever CT was suggestive of lung infection. To serve symptomatic patients who were already admitted to the hospital or in need of hospitalization while waiting for RT-PCR laboratory confirmation of infection, a COVID-19 surveillance zone was set up.
RESULTS:

A total of 301 patients were screened between March 6 and April 3, 2020. Of these, 47 were hospitalized, 53 needed a differential diagnosis to continue with their cancer treatment, and 201 were about to undergo surgery. RT-PCR was positive in 13 of 40 hospitalized patients (32%), 14 of 52 day hospital patients (27%), and 6 of 201 surgical patients (3%).
CONCLUSION:

Applying filters to protect our comprehensive cancer center from COVID-19 spread contributed to guaranteeing cancer care during the COVID-19 crisis in Milan. A surveillance area and surgical triage allowed us to protect the hospital from as many as 33 patients infected with SARS-CoV-2.



KEYWORDS:

COVID-19; SARS-CoV-2; coronavirus disease; lung infection


PMID:32364028DOI:10.1177/0300891620923790
 
Back
Top Bottom